GTS Securities’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-30,200
Closed -$3.14M 1772
2024
Q3
$3.14M Buy
30,200
+3,700
+14% +$377K 0.01% 1242
2024
Q2
$2.57M Sell
26,500
-45,300
-63% -$4.18M 0.01% 1307
2024
Q1
$6.47M Sell
71,800
-100
-0.1% -$8.47K 0.01% 704
2023
Q4
$5.73M Sell
71,900
-74,200
-51% -$5.58M 0.01% 905
2023
Q3
$10.4M Buy
+146,100
New +$10.9M 0.02% 585

Other funds holding CL

GTS Securities's CL Position: Q2 2026 in Review

GTS Securities reduced its Colgate-Palmolive (CL) stake by 68% in Q2 2026, selling an estimated $456K and leaving 2,509 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #1129.

GTS Securities first reported a position in CL in Q2 2023 and has held it in 11 quarters since. The position peaked at $1.98M in Q4 2024. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • GTS Securities held 2,509 shares of Colgate-Palmolive worth $230K as of Q2 2026.
  • GTS Securities sold 5,212 Colgate-Palmolive shares in Q2 2026, an estimated $456K.
  • Colgate-Palmolive made up ﹤0.01% of GTS Securities's portfolio in Q2 2026, its #1129 holding.
  • GTS Securities first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 11 quarters since.
  • GTS Securities's Colgate-Palmolive position peaked at $1.98M in Q4 2024.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.